Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
13.20%
↑ 183% above average
Average (16q)
-15.85%
Historical baseline
Range
High:19.39%
Low:-77.99%
Volatility
-614.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 13.20% |
| Q2 2025 | -6.74% |
| Q1 2025 | 13.80% |
| Q4 2024 | -1.74% |
| Q3 2024 | -19.38% |
| Q2 2024 | -14.02% |
| Q1 2024 | 14.37% |
| Q4 2023 | -33.08% |
| Q3 2023 | -3.97% |
| Q2 2023 | -9.08% |
| Q1 2023 | -42.86% |
| Q4 2022 | 2.92% |
| Q3 2022 | -58.04% |
| Q2 2022 | 19.39% |
| Q1 2022 | -66.24% |
| Q4 2021 | -77.99% |
| Q3 2021 | 0.00% |